Date | Programmes | Podcast Title | |
---|---|---|---|
07-Mar-25 |
Morning Brief (7:45 AM) |
Bank Negara: Malaysia's Growth Story Still Intact
Dr Mohd Afzanizam Abdul Rashid, Chief Economist, Bank Muamalat |
|
23-Jan-25 |
Morning Brief (7:45 AM) |
BNM Stays Pat On OPR At 3%
Julia Goh, Senior Economist, UOB |
|
19-Nov-24 |
Enterprise Explores (12:00 PM) |
The Ringgit, Inflation, and the Economy: What Lies Ahead?
Caroline Wong, Country Risk Analyst, BMI |
|
11-Jun-24 |
Market Watch (9:15 AM) |
Banking Sector Chugging Along Nicely
Chan Jit Hoong, Senior Analyst, Hong Leong Investment Bank |
|
11-Mar-24 |
Morning Brief (8:30 AM) |
BNM on OPR and RM
Adnan Zaylani bin Mohamad Zahid, Deputy Governor, Bank Negara Malaysia |
|
08-Mar-24 |
Morning Brief (7:45 AM) |
Bank Negara: OPR Stays At 3%, Ringgit Undervalued
Julia Goh, Senior Economist, UOB |
|
29-Jan-24 |
Today I Learned (2:00 PM) |
What is Overnight Policy Rate (OPR)?
Dr Geoffrey Williams, Economist & Professor, Malaysia University of Science and Technology (MUST) |
|
11-Sep-23 |
Morning Brief (9:15 AM) |
OPR Staying Flat And The Impact On Malaysian Bonds
Ang Beng Kuan, Head of Investments, Hong Leong Islamic Asset Management |
|
08-Sep-23 |
Top Story (7:45 AM) |
Bank Negara Maintains OPR At 3.00%
Ray Choy, Chief Economist, Malaysian Rating Corporation (MARC) |
|
07-Jul-23 |
Top Story (7:45 AM) |
Bank Negara Malaysia Keeps OPR At 3%
Julia Goh, Senior Economist, UOB Malaysia |
|
10-Mar-23 |
Morning Brief (8:30 AM) |
BNM Maintains OPR As Economy Cools
Abdul Mui'zz Morhalim, Economist, MIDF Research |
|
20-Jan-23 |
Morning Brief (8:30 AM) |
Surprise! No OPR Increase.
Julia Goh, Senior Economist, UOB Malaysia |
|
18-Jan-23 |
Morning Brief (7:45 AM) |
Is A 25bps Hike By Bank Negara Malaysia A Given?
Abdul Mui'zz Morhalim, Economist, MIDF research |
|
05-Jan-23 |
Market Watch (9:15 AM) |
Will M-REITS Stay Resilient In 2023?
Jessica Low, Senior Analyst, MIDF Amanah Investment Bank |
|
08-Dec-22 |
Market Watch (9:15 AM) |
Have Malaysian Banks Lost Their Shine?
Nabil Thoo, Research Analyst, RHB Investment |
|
14-Nov-22 |
Morning Brief (8:30 AM) |
GDP - 3Q GDP Trumps Forecast But What's Next?
Julia Goh, Senior Economist, UOB Malaysia |
The 6AM Stretch
Thought-provoking discussions on ideas, people and events shaping our lives.
World Market Watch
Tony Nash of Complete Intelligence tells us where international markets are heading.
Morning Brief
We recap global and local headlines from today's papers and portals.
Morning Brief
Heron Lim, Economist at Moody’s Analytics discusses the impact of Trump's tariffs on China's economy.
Morning Brief
Prof. Azmi Hassan, Political Analyst and Senior Fellow at the Nusantara Academy weighs in on the three cornered fight in the Ayer Kuning By-election
The Breakfast Grille
Dr Mohd Afzanizam of Bank Muamalat & Dr Ong Kian Ming of Taylor’s University discusses the impact of Trump’s tariffs on Malaysia.
Morning Brief
Dr Renato Lima de Oliveira, Institute of Democracy and Economic Affairs (IDEAS) discusses the depletion of natural gas reserves in Malaysia.
Opening Bell
(REPEAT) Tony Nash of Complete Intelligence tells us where international markets are heading.
Opening Bell
Christopher Wong, FX Strategist at OCBC speaks about the impact of Trump’s tariffs on Asian currencies.
Ringgit & Sense
Jennifer Chua, licensed Financial Advisor at UOB Kay Hian talks about the ins and outs of planning for your parents' aged care.
Open For Business
How Nexacore Aims to Solve the ‘Last Mile’ Problem in Device Insurance
Tech Talk
Breaking Up with Your Phone: The Case for a Digital Detox
Enterprise Explores
Inside Southeast Asia’s $19B Food Delivery Market
Discovery Hour
An eclectic selection of BBC shows, curated with variety in mind.
Beyond the Ballot Box
In this conversation with Jomo Kwame Sundaram, we delve into the next stage of Malaysia's development, examining economic policy, structural challenges, and pathways for equitable growth.
Health & Living
How does the Ministry of Health decide what therapies are available in the public health system? And as more innovative and expensive therapies are developed, how do we balance cost with public need?
Top 5 at 5
Talkback Thursday
BBC World Service